Applied Molecular Transport

General Information


We are a clinical-stage biopharmaceutical company leveraging our proprietary technology platform to design and develop a pipeline of novel oral biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. Our proprietary technology platform allows us to exploit existing natural cellular trafficking pathways to facilitate the active transport of therapeutic payloads across the IE barrier. Active transport is an efficient mechanism that uses the cell’s own machinery to transport materials across the IE barrier.

Employees: 49
Founded: 2016
Contact Information
Address 1 Tower Place, Suite 850, South San Francisco, CA 94080, US
Phone Number 650-392-0420
Web Address
View Prospectus: Applied Molecular Transport
Financial Information
Market Cap $453.6mil
Revenues $0 mil (last 12 months)
Net Income $-38.4 mil (last 12 months)
IPO Profile
Symbol AMTI
Exchange NASDAQ
Shares (millions): 11.0
Price range $14.00 - $14.00
Est. $ Volume $154.0 mil
Manager / Joint Managers BofA Securities/Jefferies/ SVB Leerink
CO-Managers -
Expected To Trade: 6/5/2020
Status: Priced
Quiet Period Expiration Date:
Lock-Up Period Expiration Date:
SCOOP Rating
Rating Change